Novarel is a Kit in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is .
Product ID | 55566-1501_655901b8-a886-4b78-98f8-a0739225ed7e |
NDC | 55566-1501 |
Product Type | Human Prescription Drug |
Proprietary Name | Novarel |
Generic Name | Gonadotrophin, Chorionic |
Dosage Form | Kit |
Marketing Start Date | 1974-01-15 |
Marketing Category | BLA / NDA |
Application Number | BLA017016 |
Labeler Name | Ferring Pharmaceuticals Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1974-01-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA017016 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1974-01-15 |
Marketing Category | BLA |
Application Number | BLA017016 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-01-15 |
Marketing End Date | 2012-09-25 |
SPL SET ID: | ac6918ff-9dc3-40d9-8619-54b26e4bdfc8 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
55566-1501 | Novarel | gonadotrophin, chorionic |
55566-1502 | Novarel | gonadotrophin, chorionic |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NOVAREL 75358705 2233004 Live/Registered |
Ferring B.V. 1997-09-17 |